These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24485818)

  • 21. Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea.
    Herman J; Pokkunuri V; Braham L; Pimentel M
    Gend Med; 2010 Jun; 7(3):240-6. PubMed ID: 20638629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
    Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
    Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An examination of subgroup classification in irritable bowel syndrome patients over time: a prospective study.
    Penny KI; Smith GD; Ramsay D; Steinke DT; Kinnear M; Penman ID
    Int J Nurs Stud; 2008 Dec; 45(12):1715-20. PubMed ID: 18829027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
    Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasonographic assessment of liquid gastric emptying and antral motility according to the subtypes of irritable bowel syndrome in children.
    Devanarayana NM; Rajindrajith S; Bandara C; Shashiprabha G; Benninga MA
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):443-8. PubMed ID: 23201712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM; Shiff SJ; Quigley EM
    Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polar vectors as a method for evaluating the effectiveness of irritable bowel syndrome treatments: an analysis with pinaverium bromide 100mg plus simethicone 300mg po bid.
    López-Alvarenga JC; Sobrino-Cossío S; Remes-Troche JM; Chiu-Ugalde J; Vargas-Romero JA; Schmulson M
    Rev Gastroenterol Mex; 2013; 78(1):21-7. PubMed ID: 23375823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
    Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
    Malagelada JR
    Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study.
    Fukuba N; Ishihara S; Tada Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Kushiyama Y; Fujishiro H; Kinoshita Y
    Scand J Gastroenterol; 2014 Jun; 49(6):674-80. PubMed ID: 24646420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability.
    Mearin F; Baró E; Roset M; Badía X; Zárate N; Pérez I
    Am J Gastroenterol; 2004 Jan; 99(1):113-21. PubMed ID: 14687152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of visceral hyperesthesia in irritable bowel syndrome].
    Király A; Csizmadia C; Illés A; Undi S
    Orv Hetil; 2006 Mar; 147(9):421-6. PubMed ID: 16619961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.
    Drossman DA; Morris CB; Hu Y; Toner BB; Diamant N; Leserman J; Shetzline M; Dalton C; Bangdiwala SI
    Gastroenterology; 2005 Mar; 128(3):580-9. PubMed ID: 15765393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Red flag" evaluation yield in irritable bowel syndrome.
    Black TP; Manolakis CS; Di Palma JA
    J Gastrointestin Liver Dis; 2012 Jun; 21(2):153-6. PubMed ID: 22720303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parental report of abdominal pain and abdominal pain-related functional gastrointestinal disorders from a community survey.
    Saps M; Adams P; Bonilla S; Chogle A; Nichols-Vinueza D
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):707-10. PubMed ID: 22744191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-term profile of patients with irritable bowel syndrome.
    Khokhar N; Niazi AK
    J Coll Physicians Surg Pak; 2013 Jun; 23(6):388-91. PubMed ID: 23763796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features.
    Stewart WF; Liberman JN; Sandler RS; Woods MS; Stemhagen A; Chee E; Lipton RB; Farup CE
    Am J Gastroenterol; 1999 Dec; 94(12):3530-40. PubMed ID: 10606315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.
    Hellström PM; Saito YA; Bytzer P; Tack J; Mueller-Lissner S; Chang L
    Am J Gastroenterol; 2011 Jul; 106(7):1299-307. PubMed ID: 21448146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.